Black Diamond Therapeutics, Inc.·4

Sep 20, 4:24 PM ET

Raman Prakash 4

4 · Black Diamond Therapeutics, Inc. · Filed Sep 20, 2024

Insider Transaction Report

Form 4
Period: 2024-09-20
Transactions
  • Award

    Common Stock

    2024-09-20$4.78/sh+2,694$12,8774,995 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 19, 2024.

Documents

1 file
  • 4
    form4-09202024_080904.xmlPrimary